A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L

被引:10
|
作者
Zhang, Ruxu [1 ]
Zhang, Fufeng [2 ]
Li, Xiaobo [1 ]
Huang, Shunxiang [1 ]
Zi, Xiaohong [1 ]
Liu, Ting [1 ]
Liu, Sanmei [1 ]
Li, Xuning [1 ]
Xia, Kun [3 ]
Pan, Qian [3 ]
Tang, Beisha [2 ,3 ]
机构
[1] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha 410013, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410013, Hunan, Peoples R China
[3] Cent S Univ, Natl Key Lab Med Genet, Changsha 410013, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
nerve regeneration; peripheral nerve injury; axonal injury; animal models; Charcot-Marie-Tooth disease type 2L; gene mutation; pronuclear injection; transgenic model; small heat shock protein B8; NSFC grant; neural regeneration; HSPB8 GENE MUTATION; CHAPERONE COMPLEX; NEUROPATHY; LOCUS; BAG3;
D O I
10.4103/1673-5374.128248
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We previously found that the K141N mutation in heat shock protein B8 (HSPB8) was responsible for Charcot-Marie-Tooth disease type 2L in a large Chinese family. The objective of the present study was to generate a transgenic mouse model bearing the K141N mutation in the human HSPB8 gene, and to determine whether this (K141N)HSPB8 transgenic mouse model would manifest the clinical phenotype of Charcot-Marie-Tooth disease type 2L, and consequently be suitable for use in studies of disease pathogenesis. Transgenic mice overexpressing (K141N)HSPB8 were generated using K141N mutant HSPB8 cDNA cloned into a pCAGGS plasmid driven by a human cytomegalovirus expression system. PCR and western blot analysis confirmed integration of the (K141N)HSPB8 gene and widespread expression in tissues of the transgenic mice. The (K141N)HSPB8 transgenic mice exhibited decreased muscle strength in the hind limbs and impaired motor coordination, but no obvious sensory disturbance at 6 months of age by behavioral assessment. Electrophysiological analysis showed that the compound motor action potential amplitude in the sciatic nerve was significantly decreased, but motor nerve conduction velocity remained normal at 6 months of age. Pathological analysis of the sciatic nerve showed reduced myelinated fiber density, notable axonal edema and vacuolar degeneration in (K141N)HSPB8 transgenic mice, suggesting axonal involvement in the peripheral nerve damage in these animals. These findings indicate that the (K141N)HSPB8 transgenic mouse successfully models Charcot-Marie-Tooth disease type 2L and can be used to study the pathogenesis of the disease.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 50 条
  • [1] A novel transgenic mouse model of Chinese CharcotMarie-Tooth disease type 2L
    Ruxu Zhang
    Fufeng Zhang
    Xiaobo Li
    Shunxiang Huang
    Xiaohong Zi
    Ting Liu
    Sanmei Liu
    Xuning Li
    Kun Xia
    Qian Pan
    Beisha Tang
    NeuralRegenerationResearch, 2014, 9 (04) : 413 - 419
  • [2] A transgenic rat model of Charcot-Marie-Tooth disease
    Sereda, M
    Griffiths, I
    Puhlhofer, A
    Stewart, H
    Rossner, MJ
    Zimmermann, F
    Magyar, JP
    Schneider, A
    Hund, E
    Meinck, HM
    Suter, U
    Nave, KA
    NEURON, 1996, 16 (05) : 1049 - 1060
  • [3] Charcot-Marie-Tooth disease type 2
    Vance, JM
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 42 - 46
  • [4] Type 2 Charcot-Marie-Tooth disease
    Combarros-Pascual, O
    REVISTA DE NEUROLOGIA, 2000, 30 (01) : 79 - 81
  • [5] Phenotype of Charcot-Marie-Tooth disease Type 2
    Bienfait, H. M. E.
    Baas, F.
    Koelman, J. H. T. M.
    de Haan, R. J.
    van Engelen, B. G. M.
    Gabreels-Festen, A. A. W. M.
    de Visser, B. W. Ongerboer
    Meggouh, F.
    Weterman, M. A. J.
    De Jonghe, P.
    Timmerman, V.
    de Visser, M.
    NEUROLOGY, 2007, 68 (20) : 1658 - 1667
  • [6] A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease
    Gonzalez, Michael A.
    Feely, Shawna M.
    Speziani, Fiorella
    Strickland, Alleene V.
    Danzi, Matt
    Bacon, Chelsea
    Lee, Youjin
    Chou, Tsui-Fen
    Blanton, Susan H.
    Weihl, Conrad C.
    Zuchner, Stephan
    Shy, Michael E.
    BRAIN, 2014, 137 : 2897 - 2902
  • [7] Electrophysiological trends in Charcot-Marie-Tooth disease type 2
    Jerath, Nivedita
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 252 - 252
  • [8] Charcot-Marie-Tooth Disease Type 2B
    Durdu, Senay
    Koc, Kadriye
    Balaban, Deniz
    Karaoglu, Aynur
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (02): : 65 - 67
  • [9] Charcot-Marie-Tooth disease
    Gregory T. Carter
    Michael D. Weiss
    Jay J. Han
    Phillip F. Chance
    John D. England
    Current Treatment Options in Neurology, 2008, 10 : 94 - 102
  • [10] Charcot-Marie-Tooth disease
    Szigeti, Kinga
    Lupski, James R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (06) : 703 - 710